Phytonadione Tablets 5mg, 30-count bottle, Rx Only, Manufactured For: Oceanside Pharmaceuticals, ...

FDA Drug Recall #D-0244-2021 — Class III — January 7, 2021

Recall Summary

Recall Number D-0244-2021
Classification Class III — Low risk
Date Initiated January 7, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Bausch Health Companies, Inc.
Location Bridgewater, NJ
Product Type Drugs
Quantity 14,089 bottles

Product Description

Phytonadione Tablets 5mg, 30-count bottle, Rx Only, Manufactured For: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA NDC 68682-170-30

Reason for Recall

Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.

Distribution Pattern

Distributed Nationwide in the USA

Lot / Code Information

Lot: 18L091P, Exp 05/2021

Other Recalls from Bausch Health Companies, Inc.

Recall # Classification Product Date
D-0355-2024 Class II Omeprazole and Sodium Bicarbonate For Oral Susp... Feb 2, 2024
D-0638-2021 Class III Mephyton (Phytonadione) 5 mg tablets, 100-count... Jun 8, 2021
D-0639-2021 Class III Phytonadione Tablets, 5 mg, 30-count ablets, Rx... Jun 8, 2021
D-0243-2021 Class III Mephyton (phytonadione) Tablets 5mg, 100-count ... Jan 7, 2021
D-0054-2021 Class II Hydrocortisone butyrate Cream, 0.1%, 15-gram tu... Jul 13, 2020

Frequently Asked Questions

Nitrosamines are probable human carcinogens — they can increase cancer risk with long-term exposure above certain thresholds, but they do not cause immediate harm from taking a single dose. The FDA calculates an acceptable daily intake (ADI) for each nitrosamine compound, and recalls are triggered when levels exceed this threshold. If you have been taking a recalled product, the FDA generally advises against abruptly stopping your medication (especially for critical conditions like blood pressure or diabetes) until you consult your doctor. The incremental cancer risk from short-term exposure is very small.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.